Significant association between RA and increased COPD risk seen in both genders, seropositive/seronegative RA
FRIDAY, Dec. 27, 2024 (HealthDay News) — There is a bidirectional association between rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD), according to a review published online Dec. 1 in Frontiers in Immunology.
Meijiao Wang, from the Zhejiang Chinese Medical University in Hangzhou, and colleagues examined the bidirectional association between RA and COPD in a systematic review of the literature. Data were included from 19 studies with 1,549,181 participants.
The researchers found that the risk for bias varied from low to moderate, while evidence levels were rated low or very low. A significant association was seen between RA and increased COPD risk (odds ratio, 1.41) in a pooled analysis. In subgroup analyses, COPD risk elevations were similar in men and women, seropositive/seronegative RA, and cohort and case-control studies. In addition, individuals with COPD had an increased risk for RA (odds ratio, 1.36); in particular, this finding was seen among women and seropositive RA and in cohort studies.
“This meta-analysis indicates a significant bidirectional association between RA and COPD across the included studies,” the authors write. “Early detection of both conditions may be vital for initiating effective treatments and improving long-term outcomes.”
Abstract/Full Text (subscription or payment may be required)
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease
Use of SAMA, SABA Linked to Cardiovascular Events, Mortality in Asthma, COPD
Distinct Characteristics ID"d for Patients With Rheumatoid Conditions, Opioid Use Disorder
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus
Study Looks at Patient Experiences With Sedative Contaminating Fentanyl
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus
People Using Illicitly Sourced Fentanyl Face Worse Outcomes Than Medically Sourced Users